Alzheimer's
A disease that affects memory and thinking ability, and is the most common cause of dementia.
October 17, 2023
The end of the beginning for Alzheimer's patients
Leo Stenz is the first IU Health patient to receive a new Alzheimer's medication called Lecanemab, a first-of-its-kind, FDA approved drug that's shown to significantly slow a patient's cognitive decline. "It gave me some excitement that something is coming around the corner," said Leo, who doctors diagnosed with Alzheimer's disease about two years ago.